Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-30 @ 2:42 AM
Study NCT ID:
NCT07392060
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-06
First Post:
2026-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment
Sponsor:
Shanghai Jiatan Pharmatech Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-28
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-20
First Submit QC Date:
None
Study First Post Date:
2026-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-04
Last Update Post Date:
2026-02-06
Last Update Post Date Type:
ACTUAL